Commodore Capital LP 13D and 13G filings for Karyopharm Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:06 pm Sale | 2022-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI | Commodore Capital LP | 129,041 1.700% | -138,363 (-51.74%) | Filing |
| 2022-05-09 4:30 pm Purchase | 2022-04-27 | 13G | Karyopharm Therapeutics Inc. KPTI | Commodore Capital LP | 267,403 5.100% | 267,403 (New Position) | Filing |